One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2021-146820
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 7 |
Affiliation: Tufts Medical Center, University Hospital Heidelberg, Heidelberg University, Centre Hospitalier Universitaire de Limoges, University of Pavia, University Medical Center Utrecht, Janssen (United States), City of Hope, Japanese Red Cross Medical Center, Janssen (Netherlands), The Ohio State University, Princess Alexandra Hospital, Boston Medical Center, Boston University, University of California, San Francisco, Peking University People's Hospital, Peking University, Mayo Clinic, The University of Texas MD Anderson Cancer Center, National and Kapodistrian University of Athens, Cleveland Clinic, Hadassah Medical Center, Ankara University, São Germano Oncologia, University College London, Monash University, Sungkyunkwan University, Samsung Medical Center, University of Washington Medical Center, University of Alberta, University of Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
Subcutaneous Daratumumab with Bortezomib, Cyclophosphamide, and Dexamethasone in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: 18-Month Analysis of the Phase 3 ANDROMEDA Study
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
